SCHEMBL29800885

SCHEMBL29800885

CSCC[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ NAA50 Q9GZZ1 1/20 0.47
▸ CTSL P07711 3/20 0.40
▸ CTSS P25774 3/20 0.40
▸ CTSK P43235 3/20 0.40
▸ CTSH P09668 1/20 0.40
▸ APLNR P35414 2/20 0.39
▸ OPRM1 P35372 1/20 0.39
▸ OPRD1 P41143 1/20 0.39
▸ CCKBR P32239 4/20 0.38
▸ PTPN1 P18031 1/20 0.37
▸ NTSR1 P30989 1/20 0.37
▸ NMUR2 Q9GZQ4 1/20 0.37
▸ NMUR1 Q9HB89 1/20 0.37
▸ GRPR P30550 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31067246 0.93 PTPN1 (0.43) NAA50APLNROPRD1PTPN1NTSR1
SCHEMBL29904041 0.92 APLNR (0.41) NAA50APLNROPRM1OPRD1PTPN1
SCHEMBL29800494 0.91 OPRM1 (0.44) APLNROPRM1OPRD1NMUR2NMUR1
SCHEMBL30493464 0.90 APLNR (0.42) NAA50APLNROPRM1OPRD1PTPN1
SCHEMBL5495351 0.90 NAA50 (0.54) NAA50APLNRNTSR1NMUR2NMUR1
SCHEMBL30563219 0.89 NAA50 (0.44) NAA50PTPN1NTSR1
SCHEMBL29904042 0.87 APLNR (0.42) APLNROPRM1OPRD1PTPN1NTSR1
SCHEMBL29569246 0.87 NTSR1 (0.44) APLNROPRD1PTPN1NTSR1
SCHEMBL29800900 0.86 NTSR1 (0.48) OPRD1PTPN1NTSR1
SCHEMBL30933089 0.85 NAA50 (0.48) NAA50APLNRNTSR1NMUR2NMUR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109422799-B Docetaxel liver cancer-resisting targeted prodrug and medicinal application thereof 复旦大学 2022-07-29 — — CN claimed
CN-109422799-B Docetaxel liver cancer-resisting targeted prodrug and medicinal application thereof 复旦大学 2022-07-29 — — CN disclosed
Send feedback